Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2011 by Yokohama City University Medical Center.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Yasushi Matsuzawa, Yokohama City University Medical Center
ClinicalTrials.gov Identifier:
NCT01484158
First received: November 30, 2011
Last updated: December 1, 2011
Last verified: December 2011

November 30, 2011
December 1, 2011
October 2001
December 2011   (final data collection date for primary outcome measure)
Cardiovascular Events [ Time Frame: 5 years ] [ Designated as safety issue: No ]
cardiovascular death, non-fatal myocardial infarction and non-fatal stroke
Same as current
Complete list of historical versions of study NCT01484158 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction
Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction

There are growing evidences that gait speed is inversely associated with all causes mortality especially cardiovascular mortality among the elderly. The purpose of this study is to evaluate the predictive value of gait speed for cardiovascular events in patients after ST-segment elevation myocardial infarction (STEMI).

The investigators will enroll patients capable of walking with STEMI. All patients will receive successful reperfusion therapy within 12-hour from onset. Gait speed during cardiac rehabilitation is measured. Cardiovascular events were defined as a composite of cardiovascular death, non-fatal myocardial infarction and non-fatal stroke, for an average follow-up period.

Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:

We retain only blood sample only in this study.

Probability Sample

Patients with acute myocardial infarction.

Myocardial Infarction
Not Provided
Myocardial Infarction
Patients with myocardial infarction
Matsuzawa Y, Konishi M, Akiyama E, Suzuki H, Nakayama N, Kiyokuni M, Sumita S, Ebina T, Kosuge M, Hibi K, Tsukahara K, Iwahashi N, Endo M, Maejima N, Saka K, Hashiba K, Okada K, Taguri M, Morita S, Sugiyama S, Ogawa H, Sashika H, Umemura S, Kimura K. Association between gait speed as a measure of frailty and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol. 2013 May 14;61(19):1964-72. doi: 10.1016/j.jacc.2013.02.020. Epub 2013 Mar 14.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
450
December 2011
December 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Clinical diagnosis of ST-segment elevation acute myocardial infarction
  • Must be treated within 12 hours after symptom onset
  • Must be able to walk
  • Must receive successful primary percutaneous coronary intervention

Exclusion Criteria:

  • History of prior myocardial infarction
  • Cerebrovascular disease with residual hemiplegia
  • Severe peripheral arterial disease
Both
30 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT01484158
Gait Speed Outcome Study
No
Yasushi Matsuzawa, Yokohama City University Medical Center
Yokohama City University Medical Center
Not Provided
Not Provided
Yokohama City University Medical Center
December 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP